Meeting
2023 ASCO Annual Meeting
Cardiotoxicity surveillance among patients with cancer treated with immunotherapy.
Authors
Juliana Goes Martins Fagundes
Oncoclinicas Paraiba (Centro Paraibano de Oncologia), Joao Pessoa, Brazil
Juliana Goes Martins Fagundes , Matheus Coelho Torres , Thiago Lins Fagundes de Sousa , Luis Fabio Botelho , Eudanusia Guilherme de Figueiredo , Rodrigo de Carvalho Flamini , Emilio Carlos De Arruda Lacerda , Jean Fabrício De Lima Pereira , Igor Lemos Duarte , Gilberto Castro Jr., Marcelo Dantas Tavares de Melo , Silvia Moreira Ayub Ferreira
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Other IO-Related Topics
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 2636)
DOI
10.1200/JCO.2023.41.16_suppl.2636
Abstract #
2636
Poster Bd #
478
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Fasting mimicking diet reduces anti-OX40/anti PD-L1 and anti-PD-1/anti-CTLA-4 cardiovascular side effects in preclinical melanoma models.
First Author: Vincenzo Quagliariello
Poster
2022 ASCO Annual Meeting
Immune-related adverse events and immunotherapy efficacy in patients with cancer: A retrospective study.
First Author: Lyndsey L Prather
Poster
2021 ASCO Annual Meeting
Real-world outcomes in older adults treated with immunotherapy: A United Kingdom multicenter series of 2,049 patients.
First Author: Anna Claire Olsson-Brown
Poster
2020 ASCO Virtual Scientific Program
Administration of immune checkpoint inhibitors using teleoncology model of care in Far North Queensland: A multicenter review of safety outcomes.
First Author: James Fletcher